HLA-DQA2 and Huntington disease: Compared to the HC group, HD patients showed reduced JAK1, FOS, JUN, and mTOR levels in CD4+ T cells, and decreased levels of HLA-DQA1, HLA-DQA2, and HLA-DRB1 in monocytes, which was consistent with the scRNA-seq data (Figure 6D).